Table of Content

1. Executive Summary
   1.1. Global Infectious Disease In-Vitro Diagnostics Market Snapshot, 2024 and 2031
   1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
   1.3. Key Market Trends
   1.4. Future Market Projections
   1.5. Premium Market Insights
   1.6. Industry Developments and Key Market Events
   1.7. PMR Analysis and Recommendations
2. Market Overview
   2.1. Market Scope and Definition
   2.2. Market Dynamics
       2.2.1. Drivers
       2.2.2. Restraints
       2.2.3. Opportunity
       2.2.4. Challenges
       2.2.5. Key Trends
   2.3. Macro-Economic Factors
       2.3.1. Global Sectorial Outlook
       2.3.2. Global GDP Growth Outlook
       2.3.3. Global Healthcare Spending Outlook
   2.4. COVID-19 Impact Analysis
   2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
   3.1. Regulatory Landscape
   3.2. Product Adoption Analysis
   3.3. Value Chain Analysis
   3.4. Key Deals and Mergers
   3.5. Parent Market Analysis
   3.6. PESTLE Analysis
   3.7. Porter’s Five Force Analysis
4. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   4.1. Key Highlights
       4.1.1. Market Size (US$ Bn) and Y-o-Y Growth
       4.1.2. Absolute $ Opportunity
   4.2. Market Size (US$ Bn) Analysis and Forecast
       4.2.1. Historical Market Size (US$ Bn) Analysis, 2019-2023
       4.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2023-2031
   4.3. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Product Type
       4.3.1. Introduction / Key Findings
       4.3.2. Historical Market Size (US$ Bn) Analysis, By Product Type, 2019 - 2023
       4.3.3. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
           4.3.3.1. Instruments
           4.3.3.2. Reagents
           4.3.3.3. Software and Services
   4.4. Market Attractiveness Analysis: Product Type
   4.5. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Technology
       4.5.1. Introduction / Key Findings
       4.5.2. Historical Market Size (US$ Bn) Analysis, By Technology, 2019 - 2023
       4.5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
           4.5.3.1. Immunoassay
           4.5.3.2. Molecular Diagnostics
           4.5.3.3. Microbiology
           4.5.3.4. Others
   4.6. Market Attractiveness Analysis: Technology
   4.7. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Application
       4.7.1. Introduction / Key Findings
       4.7.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
       4.7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
           4.7.3.1. MRSA
           4.7.3.2. Clostridium Difficile
           4.7.3.3. Respiratory Virus
           4.7.3.4. TB and Drug-resistant TB
           4.7.3.5. Gonorrhea
           4.7.3.6. HPV
           4.7.3.7. HIV
           4.7.3.8. Hepatitis C
           4.7.3.9. Hepatitis B
           4.7.3.10. COVID-19
           4.7.3.11. Others
   4.8. Market Attractiveness Analysis: Application
   4.9. Global Infectious Disease In-Vitro Diagnostics Market Outlook: End User
       4.9.1. Introduction / Key Findings
       4.9.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
       4.9.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
           4.9.3.1. Point-of-care
           4.9.3.2. Central Laboratories
           4.9.3.3. Others
   4.10. Market Attractiveness Analysis: End User
5. Global Infectious Disease In-Vitro Diagnostics Market Outlook: Region
   5.1. Key Highlights
   5.2. Historical Market Size (US$ Bn) Analysis, By Region, 2019 - 2023
   5.3. Current Market Size (US$ Bn) Analysis and Forecast, By Region, 2023 - 2031
       5.3.1. North America
       5.3.2. Europe
       5.3.3. East Asia
       5.3.4. South Asia and Oceania
       5.3.5. Latin America
       5.3.6. Middle East & Africa
   5.4. Market Attractiveness Analysis: Region
6. North America Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   6.1. Key Highlights
   6.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       6.2.1. By Country
       6.2.2. By Product Type
       6.2.3. By Technology
       6.2.4. By Application
       6.2.5. By End User
   6.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       6.3.1. U.S.
       6.3.2. Canada
   6.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
       6.4.1. Instruments
       6.4.2. Reagents
       6.4.3. Software and Services
   6.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       6.5.1. Immunoassay
       6.5.2. Molecular Diagnostics
       6.5.3. Microbiology
       6.5.4. Others
   6.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       6.6.1. MRSA
       6.6.2. Clostridium Difficile
       6.6.3. Respiratory Virus
       6.6.4. TB and Drug-resistant TB
       6.6.5. Gonorrhea
       6.6.6. HPV
       6.6.7. HIV
       6.6.8. Hepatitis C
       6.6.9. Hepatitis B
       6.6.10. COVID-19
       6.6.11. Others
   6.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       6.7.1. Point-of-care
       6.7.2. Central Laboratories
       6.7.3. Others
   6.8. Market Attractiveness Analysis
7. Europe Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   7.1. Key Highlights
   7.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       7.2.1. By Country
       7.2.2. By Product Type
       7.2.3. By Technology
       7.2.4. By Application
       7.2.5. By End User
   7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       7.3.1. Germany
       7.3.2. France
       7.3.3. U.K.
       7.3.4. Italy
       7.3.5. Spain
       7.3.6. Russia
       7.3.7. Türkiye
       7.3.8. Rest of Europe
   7.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
       7.4.1. Instruments
       7.4.2. Reagents
       7.4.3. Software and Services
   7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       7.5.1. Immunoassay
       7.5.2. Molecular Diagnostics
       7.5.3. Microbiology
       7.5.4. Others
   7.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       7.6.1. MRSA
       7.6.2. Clostridium Difficile
       7.6.3. Respiratory Virus
       7.6.4. TB and Drug-resistant TB
       7.6.5. Gonorrhea
       7.6.6. HPV
       7.6.7. HIV
       7.6.8. Hepatitis C
       7.6.9. Hepatitis B
       7.6.10. COVID-19
       7.6.11. Others
   7.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       7.7.1. Point-of-care
       7.7.2. Central Laboratories
       7.7.3. Others
   7.8. Market Attractiveness Analysis
8. East Asia Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   8.1. Key Highlights
   8.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       8.2.1. By Country
       8.2.2. By Product Type
       8.2.3. By Technology
       8.2.4. By Application
       8.2.5. By End User
   8.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       8.3.1. China
       8.3.2. Japan
       8.3.3. South Korea
   8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
       8.4.1. Instruments
       8.4.2. Reagents
       8.4.3. Software and Services
   8.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       8.5.1. Immunoassay
       8.5.2. Molecular Diagnostics
       8.5.3. Microbiology
       8.5.4. Others
   8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       8.6.1. MRSA
       8.6.2. Clostridium Difficile
       8.6.3. Respiratory Virus
       8.6.4. TB and Drug-resistant TB
       8.6.5. Gonorrhea
       8.6.6. HPV
       8.6.7. HIV
       8.6.8. Hepatitis C
       8.6.9. Hepatitis B
       8.6.10. COVID-19
       8.6.11. Others
   8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       8.7.1. Point-of-care
       8.7.2. Central Laboratories
       8.7.3. Others
   8.8. Market Attractiveness Analysis
9. South Asia & Oceania Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   9.1. Key Highlights
   9.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       9.2.1. By Country
       9.2.2. By Product Type
       9.2.3. By Technology
       9.2.4. By Application
       9.2.5. By End User
   9.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       9.3.1. India
       9.3.2. Southeast Asia
       9.3.3. ANZ
       9.3.4. Rest of South Asia & Oceania
   9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
       9.4.1. Instruments
       9.4.2. Reagents
       9.4.3. Software and Services
   9.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       9.5.1. Immunoassay
       9.5.2. Molecular Diagnostics
       9.5.3. Microbiology
       9.5.4. Others
   9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       9.6.1. MRSA
       9.6.2. Clostridium Difficile
       9.6.3. Respiratory Virus
       9.6.4. TB and Drug-resistant TB
       9.6.5. Gonorrhea
       9.6.6. HPV
       9.6.7. HIV
       9.6.8. Hepatitis C
       9.6.9. Hepatitis B
       9.6.10. COVID-19
       9.6.11. Others
   9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       9.7.1. Point-of-care
       9.7.2. Central Laboratories
       9.7.3. Others
   9.8. Market Attractiveness Analysis
10. Latin America Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   10.1. Key Highlights
   10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       10.2.1. By Country
       10.2.2. By Product Type
       10.2.3. By Technology
       10.2.4. By Application
       10.2.5. By End User
   10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       10.3.1. Brazil
       10.3.2. Mexico
       10.3.3. Rest of Latin America
   10.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
       10.4.1. Instruments
       10.4.2. Reagents
       10.4.3. Software and Services
   10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       10.5.1. Immunoassay
       10.5.2. Molecular Diagnostics
       10.5.3. Microbiology
       10.5.4. Others
   10.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       10.6.1. MRSA
       10.6.2. Clostridium Difficile
       10.6.3. Respiratory Virus
       10.6.4. TB and Drug-resistant TB
       10.6.5. Gonorrhea
       10.6.6. HPV
       10.6.7. HIV
       10.6.8. Hepatitis C
       10.6.9. Hepatitis B
       10.6.10. COVID-19
       10.6.11. Others
   10.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       10.7.1. Point-of-care
       10.7.2. Central Laboratories
       10.7.3. Others
   10.8. Market Attractiveness Analysis
11. Middle East & Africa Infectious Disease In-Vitro Diagnostics Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)
   11.1. Key Highlights
   11.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
       11.2.1. By Country
       11.2.2. By Product Type
       11.2.3. By Technology
       11.2.4. By Application
       11.2.5. By End User
   11.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
       11.3.1. GCC Countries
       11.3.2. Egypt
       11.3.3. South Africa
       11.3.4. Northern Africa
       11.3.5. Rest of Middle East & Africa
   11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Product Type, 2023 - 2031
       11.4.1. Instruments
       11.4.2. Reagents
       11.4.3. Software and Services
   11.5. Current Market Size (US$ Bn) Analysis and Forecast, By Technology, 2023 - 2031
       11.5.1. Immunoassay
       11.5.2. Molecular Diagnostics
       11.5.3. Microbiology
       11.5.4. Others
   11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
       11.6.1. MRSA
       11.6.2. Clostridium Difficile
       11.6.3. Respiratory Virus
       11.6.4. TB and Drug-resistant TB
       11.6.5. Gonorrhea
       11.6.6. HPV
       11.6.7. HIV
       11.6.8. Hepatitis C
       11.6.9. Hepatitis B
       11.6.10. COVID-19
       11.6.11. Others
   11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
       11.7.1. Point-of-care
       11.7.2. Central Laboratories
       11.7.3. Others
   11.8. Market Attractiveness Analysis
12. Competition Landscape
   12.1. Market Share Analysis, 2023
   12.2. Market Structure
       12.2.1. Competition Intensity Mapping By Market
       12.2.2. Competition Dashboard
   12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
       12.3.1. QIAGEN
           12.3.1.1. Overview
           12.3.1.2. Segments and Products
           12.3.1.3. Key Financials
           12.3.1.4. Market Developments
           12.3.1.5. Market Strategy
       12.3.2. Becton, Dickinson and Company
       12.3.3. bioMérieux SA
       12.3.4. F. Hoffmann-La Roche, Ltd.
       12.3.5. Hologic, Inc. (Gen Probe)
       12.3.6. Abbott
       12.3.7. Quidel Corporation
       12.3.8. Siemens Healthineers AG
       12.3.9. Bio-Rad Laboratories, Inc.
       12.3.10. Danaher
       12.3.11. OraSure Technologies, Inc.
13. Appendix
   13.1. Research Methodology
   13.2. Research Assumptions
   13.3. Acronyms and Abbreviations